share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer KASINGER JAMES R.

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer KASINGER JAMES R.

CRISPR Therapeutics | 4：持股變動聲明-高管 KASINGER JAMES R.
SEC announcement ·  03/13 05:49
牛牛AI助理已提取核心訊息
James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics, engaged in multiple transactions involving the company's common stock between March 10, 2024, and March 12, 2024. Kasinger acquired a total of 7,750 shares through the exercise of derivative securities on March 10 and March 11. Subsequently, he sold 2,801 shares on March 11 at a price of $78.26 per share and 1,146 shares on March 12 at $74.44 per share, resulting in a total sale value of approximately $304,514.50. Following these transactions, Kasinger's direct holdings in CRISPR Therapeutics common stock amounted to 61,174 shares. The transactions are reported to be in progress.
James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics, engaged in multiple transactions involving the company's common stock between March 10, 2024, and March 12, 2024. Kasinger acquired a total of 7,750 shares through the exercise of derivative securities on March 10 and March 11. Subsequently, he sold 2,801 shares on March 11 at a price of $78.26 per share and 1,146 shares on March 12 at $74.44 per share, resulting in a total sale value of approximately $304,514.50. Following these transactions, Kasinger's direct holdings in CRISPR Therapeutics common stock amounted to 61,174 shares. The transactions are reported to be in progress.
CRISPR Therapeutics總法律顧問兼秘書詹姆斯·卡辛格在2024年3月10日至2024年3月12日期間參與了多筆涉及公司普通股的交易。卡辛格於3月10日和3月11日通過行使衍生證券，共收購了7,750股股票。隨後，他在3月11日以每股78.26美元的價格出售了2,801股股票，並於3月12日以每股74.44美元的價格出售了1,146股股票，總銷售價值約爲304,514.50美元。這些交易之後，卡辛格直接持有的CRISPR Therapeutics普通股爲61,174股。據報告，交易正在進行中。
CRISPR Therapeutics總法律顧問兼秘書詹姆斯·卡辛格在2024年3月10日至2024年3月12日期間參與了多筆涉及公司普通股的交易。卡辛格於3月10日和3月11日通過行使衍生證券，共收購了7,750股股票。隨後，他在3月11日以每股78.26美元的價格出售了2,801股股票，並於3月12日以每股74.44美元的價格出售了1,146股股票，總銷售價值約爲304,514.50美元。這些交易之後，卡辛格直接持有的CRISPR Therapeutics普通股爲61,174股。據報告，交易正在進行中。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。